Today's top medical abstracts
Rheumatology
Become a Member Today!
Email
Password
Remember me
Forgot your Password?

Invite Code?

Home
General Rheumatology
For Practicing
Rheumatologists
Conferences
Jobs
Newsletters
My Library
Topics in
Rheumatology
        Amyloidosis
        Autoimmune/Heritable
        Basic Science/Genetics
        Bone Metabolism
        Chr Fatigue/Fibromyalgia
        Clinical Pharmacology
        Connective Tissue Dz
        Diagnostics/Radiology
        Economics of Medicine
        Gout and Hyperuricemia
        Infectious Arthritis
        Osteoarthritis
        Other Arthritis
        Pediatric Rheumatology
        Popular Press
        Rheumatoid Arthritis
        Spondylarthropathies
        Systemic Lupus (SLE)
        Vasculitic Syndromes
 
Help
Resource Center
RSS News Feeds
Send Newsletter
to a Friend
 
Sponsor
For Practicing Rheumatologists
Today's Rheumatology News: VGX-1027 To Undergo Additional Testing For RA
D Scott Cunningham MD, PhD, MDLinx Rheumatology
Today's Rheumatology News: FDA Approves Actemra
D Scott Cunningham MD, PhD, MDLinx Rheumatology
From the Editors: New Clinical-Only Option for MDLinx!
Stephen Smith, MDLinx
  See all
Sjogren's syndrome;Inhibitor of differentiation 3 Article Summary

Click the title below to leave the MDLinx Network and go to the Journal's Website
Is inhibitor of differentiation 3 involved in human primary Sjogren's syndrome?
Rheumatology, 03/25/08
Print     Email This Article     Save in My Library   Free Abstract
Sellam J et al. - Inhibitor of differentiation 3 (Id3) expression is not impaired in salivary glandular epithelial cells (SGECs), peripheral T cells and in labial salivary glands in Sjögren's syndrome (pSS) pts. Id3-relevant single nucleotide polymorphisms (SNPs) do not give evidence of genetic predisposition in Caucasian pSS patients.

Methods
  • A study to investigate the role of Id3 in human pSS
  • Quantitative Id3 expression in peripheral T cells, cultured SGECs and in total minor salivary glands was assessed by RT-PCR in pSS pts and controls
  • After Id3 sequencing, two SNPs in a case–control study of 212 Caucasian pSS pts and 168 controls was investigated

Results
  • Quantitative Id3 expression was not decreased in pSS pts nor in SGECs, in T cells or in minor salivary glands
  • Pts and controls did not differ in allele and genotype frequencies of Id3 SNPs
  • Neither SNP was associated with a pattern of autoantibody secretion

Read a Different Specialty
Allergy/Immunology
Anesthesiology
Cardiology
Dermatology
Drugs
Emergency Medicine
Endocrinology
ENT
Family Medicine
Gastroenterology
Hematology-Oncology
Infectious Disease
Internal Medicine
Nephrology
Neurology
OB/Gyn
Ophthalmology
Orthopedics
Pediatrics
Psychiatry
Pulmonology
Radiology
Rheumatology
Surgery
Urology
Profession Index
Dentist
Hospital Administrator
Nurse
    Medical Students
Nurse Practitioner
Pharma/Drug Marketer
    Pharmacist
Physician
Physician Assistants
Article Search
Keyword:
Search:
Published within:
Sort By:
Date Relevance
    
Sponsor
About MDLinx  |  Contact  |  Advertise with MDLinx  |  Site Map  |  Privacy Policy  |  Terms of Use  |  Sign Up For Newsletters  |  Recommend this Site

English |  Español |  Français |  Deutsch |  中文 |  Руccкий |  Norsk |  Nederlands |  Português |  Italiano

©1999-2008 MDLinx, Inc.